bioAffinity Technologies(BIAF) - 2025 Q2 - Quarterly Results

Exhibit 99.1 bioAffinity Technologies Reports Second Quarter 2025 Results CyPath Lung revenues up 62% year-over-year in first six months of 2025 SAN ANTONIO, Texas (August 14, 2025) – bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on providing noninvasive, accurate detection of early-stage lung cancer and other lung diseases, today reported financial results for the three months ended June 30, 2025. Key Highlights Second Quarter 2025 Financial Results -1- ● Increased C ...